Isoliquiritigenin, a licorice flavonoid, inhibits methamphetamine-induced hyperlocomotion but not stereotypy or conditioned place preference in mice

Methamphetamines: Abuse, Health Effects and Treatment Options

Volumn , Issue , 2012, Pages 131-151

  Kitanaka, Nobue ^a   Kitanaka, Junichi ^a   Minami, Hiroki ^a   Okamoto, Masayuki ^a   Tatsuta, Tomohiro ^b   Morita, Yoshio ^c   Tanaka, Koh ichi ^a   Nishiyama, Nobuyoshi ^a   Takemura, Motohiko ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

^b Ibogawa Hospital   (Japan)

^c BAIKA WOMEN'S UNIVERSITY   (Japan)

Author keywords

Conditioned place preference; Hyperlocomotion; Isoliquiritigenin; Methamphetamine; Monoamine metabolism; Stereotypy

Indexed keywords

EID: 84879136711     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (21)

1. Blanchard RJ, Hebert M, Dulloog L, Markham C, Figueira R, Nishimura O, Newsham K, Kaawaloa JN, Blanchard DC (2000) Cocaine-induced sniffing stereotypy changes in response to threat. Pharmacol Biochem Behav 66: 249-256.
2. Chin YW, Jung HA, Liu Y, Su BN, Castoro JA, Keller WJ, Pereira MA, Kinghorn AD (2007) Anti-oxidant constituents of the roots and stolons of licorice (Glycyrrhiza glabra). J Agric Food Chem 55: 4691-4697.
3. Di Chiara G, Imperato A (1988) Drugs abused by humans preferentially increase synaptic DA concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci USA 85: 5274-5278.
4. Jang EY, Choe ES, Hwang M, Kim SC, Lee JR, Kim SG, Jeon J-P, Buono RJ, Yang CH (2008) Isoliquiritigenin suppresses cocaine-induced extracellular dopamine release in rat brain through GABAB receptor. Eur J Pharmacol 587: 124-128.
5. Jeon JP, Buono RJ, Han BG, Jang EY, Kim SC, Yang CH, Hwang M (2008) Proteomic and behavioral analysis of response to Isoliquilitigenin in brains of acute cocaine treated rats. J Proteome Res 7: 5094-5102.
6. Kantak KM (2003) Vaccines against drugs of abuse: a viable treatment option? Drugs 63: 341-352.
7. Kitanaka J, Kitanaka N, Tatsuta T, Morita Y, Takemura M (2007) Blockade of brain histamine metabolism alters methamphetamine-induced expression patteren of stereotypy in mice via histamine H1 receptors. Neuroscience 147: 765-777.
8. Kitanaka J, Kitanaka N, Tatsuta T, Hall FS, Uhl GR, Tanaka K, Nishiyama N, Morita Y, Takemura M (2009) Sigma1 receptor antagonists determine the behavioral pattern of the methamphetamine-induced stereotypy in mice. Psychopharmacology (Berl) 203: 781-792.
9. Kitanaka J, Kitanaka N, Tatsuta T, Miyoshi A, Koumoto A, Tanaka K, Nishiyama N, Morita Y, Takemura M (2010) Pretreatment with L-histidine produces a shift from methamphetamine-induced stereotypical biting to persistent locomotion in mice. Pharmacol Biochem Behav 94: 464-470.
10. Kitanaka N, Kitanaka J, Takemura M (2003) Behavioral sensitization and alteration in monoamine metabolism in mice after single versus repeated methamphetamine administration. Eur J Pharmacol 474: 63-70.
11. Kitanaka N, Kitanaka J, Takemura M (2005) Inhibition of methamphetamine-induced hyperlocomotion in mice by clorgyline, a monoamine oxidase-A inhibitor, through alteration of the 5-hydroxytryptamine turnover in the striatum. Neuroscience 130: 295-308.
12. Kitanaka N, Kitanaka J, Tatsuta T, Watabe K, Morita Y, Takemura M (2006) Methamphetamine reward in mice as assessed by conditioned place preference test with Supermex® sensors: effect of subchronic clorgyline pretreatment. Neurochem Res 31: 805-813.
13. Mori T, Ito S, Kita T, Sawaguchi T (2004) Effects of dopamine-and serotonin-related compounds on methamphetamine-induced self-injurious behavior in mice. J Pharmacol Sci 96: 459-464.
14. National Institute on Drug Abuse (2004) NIDA InfoFacts: methamphetamine. Accessed 17 Dec 2010. URL: http://www.drugabuse.gov/infofacts/methamphetamine.html
15. Seiden LS, Sabol KE, Ricaurte GA (1993) Amphetamine: effects on catecholamine systems and behavior. Annu Rev Pharmacol Toxicol 32: 639-677.
16. Shimosato K, Nagao N, Watanabe S, Kitayama S (2003) Suppressive effects of trihexyphenidyl on methamphetamine-induced dopamine release as measured by in vivo microdialysis. Synapse 49: 47-54.
17. Srisurapanont M, Jarusuraisin N, Kittirattanapaiboon P (2001) Treatment for amphetamine dependence and abuse. Cochrane Database Syst Rev 4: CD003022.
18. Sulzer D, Sonders MS, Poulsen NW, Galli A (2005) Mechanisms of neurotransmitter release by amphetamines: a review. Prog Neurobiol 75: 406-433.
19. Tada M, Shirakawa K, Matsuoka N, Mutoh S (2004) Combined treatment of quetiapine with haloperidol in animal models of antipsychotic effect and extrapyramidal side effects: comparison with risperidone and chlorpromazine. Psychopharmacology (Berl) 176: 94-100.
20. Ujike H, Sato M (2004) Clinical features of sensitization to methamphetamine observed in patients with methamphetamine dependence and psychosis. Ann NY Acad Sci 1025: 279-287.
21. Yamamoto S, Aizu E, Jiang H, Nakadate T, Kiyoton I, Wang JC, Kato R (1991) The potent anti-tumor-promoting agent isoliquiritigenin. Carcinogenesis 12: 317-323.